MINNEAPOLIS, MN — The SYMPLICITY HTN-3 trial, a phase 3 study testing catheter-based renal denervation for the treatment of resistant hypertension, failed to achieve its primary efficacy end point, ...
SAN DIEGO, CA—Renal denervation using ultrasound may be more effective than radiofrequency ablation for lowering blood pressure in patients with resistant hypertension, a preliminary head-to-head ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
SAN DIEGO, CA—Concordant with studies of other technologies for renal denervation, the presence of untreated accessory arteries was associated with a reduced blood pressure-lowering response to the ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
MINNEAPOLIS, MN — Catheter-based renal denervation for the treatment of resistant hypertension has featured prominently at recent hypertension and cardiology congresses in the past few years, with ...
It's almost impossible to keep up with what things mean on TikTok, which is mostly thanks to the users who come up with phrases, memes, and acronyms almost daily. And when one sticks, you'd better be ...
Mineralys Therapeutics announced the positive results of its Launch-HTN trial, the largest study of an aldosterone synthase inhibitor for patients with uncontrolled or treatment-resistant hypertension ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results